-
Tytuł:
-
Responding to the Challenges of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Perspectives from the Association for Molecular Pathology Infectious Disease Subdivision Leadership.
-
Autorzy:
-
Nolte FS; The Infectious Disease Subdivision Leadership of the Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina. Electronic address: .
Babady NE; The Infectious Disease Subdivision Leadership of the Association for Molecular Pathology, Rockville, Maryland; Clinical Microbiology Service, Departments of Laboratory Medicine and Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Buchan BW; The Infectious Disease Subdivision Leadership of the Association for Molecular Pathology, Rockville, Maryland; Department of Pathology, The Medical College of Wisconsin, Milwaukee, Wisconsin.
Capraro GA; The Infectious Disease Subdivision Leadership of the Association for Molecular Pathology, Rockville, Maryland; Carolinas Pathology Group, Atrium Health, Charlotte, North Carolina.
Graf EH; The Infectious Disease Subdivision Leadership of the Association for Molecular Pathology, Rockville, Maryland; Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona.
Leber AL; The Infectious Disease Subdivision Leadership of the Association for Molecular Pathology, Rockville, Maryland; Department of Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
McElvania E; The Infectious Disease Subdivision Leadership of the Association for Molecular Pathology, Rockville, Maryland; NorthShore University HealthSystem, University of Chicago, Pritzker School of Medicine, Chicago, Illinois.
Yao JDC; The Infectious Disease Subdivision Leadership of the Association for Molecular Pathology, Rockville, Maryland; Yao Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
-
Źródło:
-
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2020 Aug; Vol. 22 (8), pp. 968-974. Date of Electronic Publication: 2020 Jun 19.
-
Typ publikacji:
-
Journal Article; Review
-
Język:
-
English
-
Imprint Name(s):
-
Publication: 2011- : New York : Elsevier
Original Publication: Bethesda, MD : American Society for Investigative Pathology and the Association for Molecular Pathology, 1999-
-
MeSH Terms:
-
Betacoronavirus*
Pandemics*
Pathology, Molecular*/organization & administration
Coronavirus Infections/*epidemiology
Pneumonia, Viral/*epidemiology
COVID-19 ; Coronavirus Infections/diagnosis ; Humans ; Leadership ; Molecular Diagnostic Techniques ; Pneumonia, Viral/diagnosis ; SARS-CoV-2 ; Societies, Medical ; United States/epidemiology
-
Grant Information:
-
P30 CA008748 United States CA NCI NIH HHS
-
Entry Date(s):
-
Date Created: 20200623 Date Completed: 20200806 Latest Revision: 20210124
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC7303040
-
DOI:
-
10.1016/j.jmoldx.2020.06.003
-
PMID:
-
32565306
-
Clinical molecular laboratory professionals are at the frontline of the response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, providing accurate, high-quality laboratory results to aid in diagnosis, treatment, and epidemiology. In this role, we have encountered numerous regulatory, reimbursement, supply-chain, logistical, and systems challenges that we have struggled to overcome to fulfill our calling to provide patient care. In this Perspective from the Association for Molecular Pathology Infectious Disease Subdivision Leadership team, we review how our members have risen to these challenges, provide recommendations for managing the current pandemic, and outline the steps we can take as a community to better prepare for future pandemics.
(Copyright © 2020 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)
Erratum in: J Mol Diagn. 2020 Oct;22(10):1308. (PMID: 32866431)
